Question

The Food and Drug Administration (FDA) is investigating reports that Gamma Pharmaceutical Corporation is putting potentially harmful additives in Hyacinth, a new pain-relief medication. The FDA's demands for particular documents from Gamma
a. must be specific, but there is no limit on its burdensomeness.
b. must not be unduly burdensome, but it need not be specific.
c. must be specific and not unduly burdensome.
d. need not be specific and there is no limit on its burdensomeness.

Answer

This answer is hidden. It contains 1 characters.